Mainstream Renewable Power
ByrneWallace LLP advises Mainstream Renewable Power....
ByrneWallace advises Neuromod....
ByrneWallace advises PrioThera Limited....
Catherine Dowling is a partner in the Corporate Department specialising in Life Sciences.
Having initially trained as a solicitor in ByrneWallace LLP, Catherine has developed her career within ByrneWallace LLP, advising Irish and international clients on a wide range of corporate and commercial transactions, including private equity/venture capital, mergers and acquisitions, restructurings, and intellectual property.
Specialising in Life Sciences, Catherine has worked with a broad range of entities in the sector, from early stage university spin-out companies to publicly quoted indigenous and global pharmaceutical, biotech and medical device and diagnostic organisations.
Catherine has also advised clients on clinical trial agreements, clinical study agreements, licensing agreements, collaboration agreements, distribution agreements and various other commercial and strategic agreements.
- B.Comm, University College Dublin
- Diploma in Intellectual Property, Law Society of Ireland
Described by Legal 500 2021 as a "Next Generation Partner - Healthcare and Life Sciences" - Legal 500, 2021
'Catherine Dowling provides exceptional service. Always on top of the project.’ - Legal 500, 2021
A client compliments Catherine Dowling for her technical skills, and describes her as responsive, personable and nice to work with. - Legal 500, 2020
Catherine Dowling has a fantastic ability with an excellent “can do” manner. Nothing too much trouble. A rising star. - Legal 500, 2020
Catherine Dowling is ranked as a Next Generation Lawyer by Legal 500, 2020
Catherine Dowling is ranked as an ‘Associate to Watch’ by Chambers Europe, and a ‘Next Generation Lawyer’ by Legal 500, for the past three years.
Clients interviewed describe Catherine Dowling as “extremely diligent, hardworking and efficient, with great attention to detail.” - Chambers Europe, 2018